Industry News

Nova's CEO Forecasts Future Growth

Published on 2006-02-16. Author : SpecialChem

ATLANTA -- Nova BioGenetics, Inc. (OTC: NVBG - News), a US antimicrobial company, announces an update from the Company's CEO. During the past six months the Company has been heavily involved in a series of joint trials with major global manufacturing companies. We have been working in various industries and have tested a number of markets worldwide. Key areas where we have been particularly active include: construction, remediation, textiles, marine, paints and coatings. Details involving a long-term existing agreement between Nova, Palmer Holland, and a global leader in the Construction Industry are expected to be released in the near future.

Following a recent strategic detailed review of our business, we have begun strengthening our management team and have restructured the Company for global expansion. We have identified where additional personnel and resources will be required, and these areas will be supplemented as a key priority for this expansion.

As a direct result of our close working relationship with market leaders across a range of industries, we have been able to respond to their specific requirements by acquiring the rights to a new, uniquely powerful antimicrobial chemistry. This acquisition enhances Nova's existing suite of EPA approved registered products. The versatility and cost-effectiveness of this ground-breaking technology opens up many global business opportunities for our customers and alliance partners. That, in turn, provides the bedrock for the strong growth now anticipated during the next stage of the Company's development.

NVBG reminds all shareholders to review the company's filings with the SEC to determine the investment opportunity in the company's stock.

Overview: Nova is a US based company. From an expanding global infrastructure Nova is providing solutions to today's market demand for a mold, mildew, bacteria and virus free environment. Nova's portfolio of patented and EPA approved antimicrobial solutions has allowed them to find unique and growing opportunities in multiple industries.

Safe Harbor/Forward-looking Statements

Statements in this news release that are not historical are forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company. NVBG does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof.

Source: Nova BioGenetics, Inc.

Emerox Poloyols
Sales & Marketing Effectiveness in Chemicals - Fleming. Events
Channel Alerts

Receive weekly digests on hot topics

Back to Top